Market Place
Sourcing Support
Remix Therapeutics Reaches Milestone In Roche Collaboration Agreement
11 Jul 2024 //
PHARMABIZ
Remix Therapeutics Appoints Dominic Reynolds, Ph.D., as Chief Scientific Officer
01 Feb 2024 //
PR NEWSWIRE
Get ready for the Roche (Remix), a $30M small molecule deal
04 Jan 2024 //
FIERCE BIOTECH
Remix to Present at 6th Annual RNA-Targeted Drug Development Summit
11 Dec 2023 //
PR NEWSWIRE
Remix Therapeutics to Present at 5th Annual RNA-Targeted Drug Discovery Summit
08 Dec 2022 //
GLOBENEWSWIRE
Remix closes $70 million series B but what`s in the pipeline?
17 May 2022 //
FIERCEBIOTECH
Remix Tx to Participate in SVB Leerink Biopharma Private Company Connect
24 Mar 2022 //
PRNEWSWIRE
J&J’s Janssen unit and Remix Therapeutics strikes deal valued at up to $1B
18 Feb 2022 //
SEEKING ALPHA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.